Regeneron’s Linvoseltamab CRL Underlines Risks Of Third-Party Manufacturers

 
• By Bridget Silverman
fermentation
Several CRLs have been issued recently because of third-party manufacturer issues. • Source: Shutterstock

More from Manufacturing

More from Compliance